Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-29 Option Award |
2022-06-30 4:15 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $1 | 1,272,174 (Direct) |
View |
| 2022-06-28 Option Award |
2022-06-30 4:15 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $1.02 | 1,272,174 (Direct) |
View |
| 2022-06-27 Option Award |
2022-06-27 4:15 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $1 | 1,262,174 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-23 5:10 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
100 | $0.988 | 805,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-23 5:10 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
200 | $0.982 | 805,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-23 5:10 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
2,900 | $0.993 | 805,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-23 5:10 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
1,800 | $0.994 | 805,000 (Direct) |
View |
| 2022-06-23 Option Award |
2022-06-23 4:31 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
5,000 | $1 | 1,257,174 (Direct) |
View |
| 2021-08-02 Option Award |
2022-06-22 4:30 pm |
2022-08-02 2031-08-02 |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
752,174 | $0 | 1,352,174 (Direct) |
View |
| 2021-12-20 Option Award |
2021-12-22 5:00 pm |
2022-12-20 2031-12-20 |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
200,000 | $0 | 1,000,000 (Direct) |
View |
Ownership(A) |
2021-10-07 4:09 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Abramowitz Israel Maxx Not a 10% owner |
0 | $0 | 1,051,575 (Indirect) |
View |
Ownership(A) |
2021-10-07 4:08 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Lazer Dean Not a 10% owner |
0 | $0 | 902,600 (Indirect) |
View |
Ownership(A) |
2021-10-07 4:07 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Lazer Eric Not a 10% owner |
0 | $0 | 902,600 (Indirect) |
View |
Ownership |
2021-09-14 9:52 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Bendiabdallah Yassine Chief Operating Officer |
0 | $0 | 300,000 (Direct) |
View |
Ownership |
2021-09-14 9:50 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer |
0 | $0 | 600,000 (Direct) |
View |
Ownership |
2021-09-14 9:49 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director |
0 | $0 | 600,000 (Direct) |
View |
Ownership |
2021-09-14 9:37 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Abramowitz Israel Maxx 10% Owner |
0 | $0 | 1,051,575 (Indirect) |
View |
Ownership |
2021-09-14 9:35 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Lazer Eric 10% Owner |
0 | $0 | 902,600 (Indirect) |
View |
Ownership |
2021-09-14 9:33 pm |
N/A N/A |
Pasithea Therapeutics Corp. | KTTA | Lazer Dean 10% Owner |
0 | $0 | 902,600 (Indirect) |
View |